Buys
Open market- Shares
- Avg price
- Total value
Andrew Stewart Plump - President, R&D, Director at TAKEDA PHARMACEUTICAL CO LTD
Issuer-level insider activity
- Role
- President, R&D, Director
- Issuer ticker
- TAK on NYSE, TKPHF on OTC
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Andrew Stewart Plump in TAKEDA PHARMACEUTICAL CO LTD
Sells
Open market- Shares
- -301,235
- Avg price
- $17.73
- Total value
- -$5,339,939
Net
Past year- Shares
- -301,235
- Share %
- -100%
- Total value
- -$5,339,939
Reported holdings for Andrew Stewart Plump in TAKEDA PHARMACEUTICAL CO LTD
Form 4 holding
President, R&D, Director
TAKEDA PHARMACEUTICAL CO LTD
- Security class
- American Depositary Shares
- Shares / value
- 766,569
- Estimated value
- $13,108,329
- Report date
- 02 Sep 2026
- Price
- $17.10
- Ownership
- Direct
Form 4 holding
President, R&D, Director
TAKEDA PHARMACEUTICAL CO LTD
- Security class
- American Depositary Shares
- Shares / value
- 145,465
- Estimated value
- $2,689,647
- Report date
- 02 Sep 2026
- Price
- $18.49
- Ownership
- By Trust
Transaction history for Andrew Stewart Plump in TAKEDA PHARMACEUTICAL CO LTD
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.